242 related articles for article (PubMed ID: 16202646)
21. Interaction between hepatitis C virus and metabolic factors.
Kawaguchi Y; Mizuta T
World J Gastroenterol; 2014 Mar; 20(11):2888-901. PubMed ID: 24659880
[TBL] [Abstract][Full Text] [Related]
22. Lipid metabolism and liver disease in hepatitis C viral infection.
Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C Virus, Insulin Resistance, and Steatosis.
Kralj D; Virović Jukić L; Stojsavljević S; Duvnjak M; Smolić M; Čurčić IB
J Clin Transl Hepatol; 2016 Mar; 4(1):66-75. PubMed ID: 27047774
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin levels and insulin resistance among patients with chronic hepatitis C.
Carvalho RF; Atta AM; de Oliveira IS; Santos TPS; Santos JPA; Schinoni MI; de Sousa-Atta MLB
Acta Trop; 2018 Feb; 178():258-263. PubMed ID: 29217381
[TBL] [Abstract][Full Text] [Related]
25. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
[TBL] [Abstract][Full Text] [Related]
26. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1527-31. PubMed ID: 9225025
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
Mihm S
Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
[TBL] [Abstract][Full Text] [Related]
29. [Extrahepatic manifestations of HBV and HCV infection].
Hartmann H
Praxis (Bern 1994); 1997 Jul; 86(29-30):1163-6. PubMed ID: 9333915
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
[TBL] [Abstract][Full Text] [Related]
31. Extrahepatic manifestations of hepatitis C virus.
Sterling RK; Bralow S
Curr Gastroenterol Rep; 2006 Feb; 8(1):53-9. PubMed ID: 16510035
[TBL] [Abstract][Full Text] [Related]
32. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
33. [Steatosis, chronic hepatitis virus C infection and homocysteine].
Roblin X; Pofelski J; Zarski JP
Gastroenterol Clin Biol; 2007 Apr; 31(4):415-20. PubMed ID: 17483780
[TBL] [Abstract][Full Text] [Related]
34. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
35. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
Helaly GF; Hussein NG; Refai W; Ibrahim M
Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms and significance of liver steatosis in hepatitis C virus infection.
Negro F
World J Gastroenterol; 2006 Nov; 12(42):6756-65. PubMed ID: 17106922
[TBL] [Abstract][Full Text] [Related]
37. Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance.
Kawaguchi T; Yamagishi S; Sata M
Curr Med Chem; 2009; 16(36):4843-57. PubMed ID: 19929783
[TBL] [Abstract][Full Text] [Related]
38. Adiponectin serum level in chronic hepatitis C infection and therapeutic profile.
Peta V; Torti C; Milic N; Focà A; Abenavoli L
World J Hepatol; 2015 Jan; 7(1):44-52. PubMed ID: 25624996
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection and insulin resistance.
Bose SK; Ray R
World J Diabetes; 2014 Feb; 5(1):52-8. PubMed ID: 24567801
[TBL] [Abstract][Full Text] [Related]
40. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
